KLP Kapitalforvaltning’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.38M Buy
16,000
+10,200
+176% +$916K ﹤0.01% 927
2026
Q2
$554K Hold
5,800
– – ﹤0.01% 1470
2026
Q1
$558K Buy
5,800
+4,000
+222% +$400K ﹤0.01% 1379
2025
Q4
$175K Sell
1,800
-300
-14% -$25.7K ﹤0.01% 1885
2025
Q3
$149K Sell
2,100
-9,500
-82% -$633K ﹤0.01% 1923
2025
Q2
$694K Sell
11,600
-5,200
-31% -$285K ﹤0.01% 1177
2025
Q1
$882K Hold
16,800
– – ﹤0.01% 998
2024
Q4
$924K Buy
+16,800
New +$884K ﹤0.01% 1032

Other funds holding IRMD

KLP Kapitalforvaltning's IRMD Position: Q3 2026 in Review

KLP Kapitalforvaltning increased its iRadimed (IRMD) stake by 176% in Q3 2026, buying an estimated $916K and bringing the position to 16,000 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #927.

KLP Kapitalforvaltning first reported a position in IRMD in Q4 2024 and has held it in 8 quarters since. 212 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.

  • KLP Kapitalforvaltning held 16,000 shares of iRadimed worth $1.38M as of Q3 2026.
  • KLP Kapitalforvaltning bought 10,200 iRadimed shares in Q3 2026, an estimated $916K.
  • iRadimed made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #927 holding.
  • KLP Kapitalforvaltning first reported a position in iRadimed in Q4 2024 and has held it in 8 quarters since.
  • 212 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.